Metraipolis › archive › dc_7ab1e4cc2bf5

Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response — Europe PMC PMID:41694584

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41694584
DOI
10.7150/ijbs.127929
License (as archived)
solo-consultazione
Archived
2026-11-06T19:12:45.155Z
SHA-256 of the archived text
915d384b70b8cb4d4034df833425b1a602bea3bb2e5444c59dd519fccd8eafa8
Stable URL of this page
https://metraipolis.com/documento/dc_7ab1e4cc2bf5

How to cite

Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response — Europe PMC PMID:41694584 — Europe PMC (en), https://europepmc.org/article/MED/41694584 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ab1e4cc2bf5 (Metraipolis archive dc_7ab1e4cc2bf5, sha256 915d384b70b8cb4d4034df833425b1a602bea3bb2e5444c59dd519fccd8eafa8)
BibTeX
@misc{dc7ab1e4cc2bf5,
  title = {Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response — Europe PMC PMID:41694584},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41694584},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ab1e4cc2bf5; sha256 915d384b70b8cb4d4034df833425b1a602bea3bb2e5444c59dd519fccd8eafa8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41694584. Agents can read the archived copy with the MCP tool read_document.